Related Experiment Video
Updated: Aug 31, 2025
12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
1.8K
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang1, Edo Kon2,3,4,5, Xuexiang Han6
1Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nature Nanotechnology
|August 18, 2022
Summary
Nanotechnology offers innovative strategies to combat emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. This research explores nanotechnology-based solutions for current and future variants of the coronavirus disease 2019 (COVID-19) pandemic.
Area of Science:
- * Nanotechnology and infectious disease research.
- * Immunology and virology.
- * Vaccine development and variant analysis.
Background:
- * The COVID-19 pandemic, caused by SARS-CoV-2, has infected over 500 million globally.
- * Nanotechnology has been crucial in developing effective mRNA vaccines against SARS-CoV-2.
- * Emerging SARS-CoV-2 variants pose a significant threat, necessitating new strategies.
Purpose of the Study:
- * To discuss SARS-CoV-2 variants from biological and immunological viewpoints.
- * To propose novel nanotechnology-based strategies against current and future variants.
- * To leverage insights from the SARS-CoV-2 fight for other infectious diseases.
Main Methods:
- * Review of biological and immunological characteristics of SARS-CoV-2 variants.
- * Analysis of existing nanotechnology applications in vaccine development.
- * Conceptualization of rational design for new nanotechnology-based interventions.
Main Results:
- * Nanotechnology-based mRNA vaccines demonstrated high efficacy against the original SARS-CoV-2 strain.
- * Emerging variants have reduced vaccine effectiveness, leading to new pandemic waves.
- * Novel nanotechnology strategies are essential to address variant-driven challenges.
Conclusions:
- * Continued innovation in nanotechnology is vital for combating SARS-CoV-2 variants.
- * The strategies developed for SARS-CoV-2 can inform responses to future infectious disease threats.
- * Nanotechnology holds promise for developing next-generation vaccines and therapeutics.
More Related Videos
Related Concept Videos
02:30siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K
01:29Microorganisms in Medicine and Therapeutics
248
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
248